BioSpace News Archive

Aegle Therapeutics Corporation , a first-in-class biotechnology company committed to delivering cell-free therapy to patients affected by severe dermatological conditions, today announced that the FDA has granted Rare Pediatric Disease (RPD) Designation to AGLE-102™ for the treatment of dystrophic epidermolysis bullosa (DEB),

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced an oral presentation at the International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group (ISIRV-AVG) Virtual Conference on Therapeutics for COVID-19 taking place from October 6 - 8, 2020.

Unchained Labs, the life sciences company that’s all about getting researchers the right tool for the job, launched its new gene therapy quantification application on Stunner

VANCOUVER, BC, Oct. 6, 2020 /PRNewswire/ - CRH Medical Corporation, announced a start-up joint venture in North Carolina.

HUYA Bioscience International (HUYABIOTM ), the leader in accelerating global development of China’s pharmaceutical innovations, today announced the submission of a regulatory application to the Japanese Pharmaceuticals and Medical Devices Agency for HBI-8000 monotherapy for relapsed or refractory (R/R) adult T-cell leukemia/lymphoma (ATL).

Acquist Therapeutics, Inc., a biopharmaceutical company committed to bettering the lives of people with inflammatory diseases, announced it will present an update of the company’s scientific and clinical plans at 2020 BIO Investor Forum Digital 2020.

NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today provides an update on its commercialization plans.

Proveris Scientific Corporation, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced its research collaboration with The University of Sydney and Macquarie University on a project to develop a new generation of technologies for improving the measurement of pharmaceutical aerosols.

PRC Clinical has galvanized its brand and website to reflect its increasingly specialized, high-touch approach to early phase clinical research.

Molecular diagnostics company Lucence today announced the availability of the world’s first assay kit to directly profile SARS-CoV-2 subgenomic RNA (sgRNA), a marker of active viral replication1, from clinical samples.